Results 261 to 270 of about 63,359 (335)

NIMG-02VOLUMETRIC RELATIONSHIP BETWEEN 2-HYDROXYGLUTARATE AND FLAIR HYPERINTENSITY IN PATIENTS WITH MUTANT IDH1 GLIOMA [PDF]

, 2015
Kourosh Jafari‐Khouzani, Franziska Loebel, Wolfgang Bogner, Elizabeth R. Gerstner, Andrew Chi, Tracy T. Batchelor, Bruce R. Rosen, Jan Unkelbach, Helen A. Shih, Daniel P. Cahill, Ovidiu C. Andronesi   +10 more
openalex   +1 more source

TMIC-13MUTANTIDH1/2SUPPRESSES LOCAL AND SYSTEMIC THROMBOSIS IN GLIOMA PATIENTS [PDF]

, 2015
Steven R. Schwarze, Laith Khoury, Cheddhi Thomas, Carolina Benjamin, Rui Chen, Li Chen, Yinxing Liu, Kristine Song, Caleb A. Dawson, Donato Pacione, David Zagzag, Thomas M. McIntyre, Matija Snuderl, Craig Horbinski   +13 more
openalex   +1 more source

Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor models. [PDF]

J Biol Chem
Schwartz AV, Chao G, Robinson M, Conley BM, Ahmed Adam MA, Wells GA, Hoang A, Albekioni E, Gallo C, Weeks J, Yunker K, Quichocho G, George UZ, Niesman I, House CD, Turcan Ş, Sohl CD.   +16 more
europepmc   +1 more source

TMOD-08A MOUSE MODEL OF YOUNG ADULT GLIOBLASTOMA: IN VIVO EXPRESSION OF MUTATED IDH1 (R132H) GENE USING THE SLEEPING BEAUTY TRANSPOSASE SYSTEM [PDF]

, 2015
Felipe J. Núñez, Flor Mendez, Carl Koshmann, Anda‐Alexandra Calinescu, Marta Dzaman, Pedro R. Löwenstein, María G. Castro   +6 more
openalex   +1 more source

In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination. [PDF]

J Immunother Cancer
Zelba H, Shao B, Rabsteyn A, Reinhardt A, Greve C, Oenning L, Kayser S, Kyzirakos C, Latzer P, Riedlinger T, Bartsch O, Wünsche J, Harter J, Feldhahn M, Bantel Y, Johänning J, Ködding J, Hadaschik D, Schulze M, Battke F, Maksimovic O, Scheble V, Miller AM, Castro M, Blumenthal DT, Glas M, Reardon D, Biskup S.   +27 more
europepmc   +1 more source

Isocitrate dehydrogenase 1 gene mutations: a case review unveiling its biological impact on disease progression, prognosis and treatment in Chilean patients. [PDF]

BJR Case Rep
de Mayo Glasser T, García-Bloj B, Godoy JA, Sigler Chávez F, Retamal IN, Gómez-Valenzuela F, Silva I, Muñoz-Medel M, Sánchez C, Pinto F, Aravena P, Corvalán I, Erpel JM, Manque PA, Garrido M.   +14 more
europepmc   +1 more source

Prognostic impact of co-mutations in adults with <i>IDH1/2</i>-mutated acute myeloid leukemia. [PDF]

Blood Sci
Lai A, Liu W, Zhou C, Li Y, Wei S, Liu K, Gong B, Gong X, Liu Y, Zhang G, Zhang J, Gu R, Qiu S, Liu B, Wang Y, Wei H, Mi Y, Wang J.   +17 more
europepmc   +1 more source

HumanTERTpromoter mutation enables survival advantage fromMGMTpromoter methylation inIDH1wild-type primary glioblastoma treated by standard chemoradiotherapy [PDF]

, 2016
HuyTram N. Nguyen, Amy Lie, Tie Li, Reshmi Chowdhury, Fei Liu, Byram H. Ozer, Bowen Wei, Richard M. Green, Benjamin M. Ellingson, He-Jing Wang, Robert M. Elashoff, Linda M. Liau, William H. Yong, Phioanh L. Nghiemphu, Timothy F. Cloughesy, Albert Lai   +15 more
openalex   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy forIDH1mutant glioma [PDF]

, 2016
Hiroaki Nagashima, Kazuhiro Tanaka, Takashi Sasayama, Yasuhiro Irino, Naoko Sato, Kosei Takeuchi, Katsusuke Kyotani, Akitake Mukasa, Katsu Mizukawa, Junichi Sakata, Yusuke Yamamoto, Kohkichi Hosoda, Tomoo Itoh, Ryohei Sasaki, Eiji Kohmura   +14 more
openalex   +1 more source